|
|
| Unlocking The Truth Behind Large CROs: Exposing The Great Talent Misconception | Large CROs have a vast pool of resources and a subset of amazingly talented people. However, the decision to select such a CRO on the concept that they have access to the best talent, and the hope that those resources will be assigned to your study, is flawed. Discover ways to overcome those faults by creating a culture where excellence, grit, and patient-centricity thrive. |
|
|
|
|
BioCryst's chief R&D officer provides examples of how AI and machine learning tools are being used to improve rare disease drug discovery and development. |
|
|
|
When should a brand become two brands? Charles River Associates provide analyses and case studies of dual brands to elucidate the pros and cons. |
|
|
|
| Unlocking Scalability In Pharma With AI | Uncover how artificial intelligence and machine learning could emerge as the most pivotal technologies of our era, with the potential to facilitate scalability in pharmaceuticals and other industries. |
|
|
|
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
